Texas Instruments (TXN) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
9 Jul, 2026Executive summary
Q2 2024 revenue was $3.82B, up 4% sequentially but down 16% year-over-year; net income was $1.13B and EPS was $1.22, including a $0.05 benefit from non-recurring items.
Industrial and automotive markets declined sequentially, while personal electronics, communication equipment, enterprise systems, and China rebounded strongly.
Free cash flow for the trailing 12 months was $1.5B, with $4.9B returned to shareholders over the same period.
$3.7B invested in R&D and SG&A, $5.0B in capital expenditures over the past year.
Financial highlights
Gross profit was $2.21B (57.8% margin), down from $2.91B (64.2%) year-over-year.
Operating profit was $1.25B (32.7% margin), down 37% year-over-year.
Net income for Q2 2024 was $1.13B, or $1.22 per share, down 35% year-over-year.
Free cash flow for the trailing 12 months was $1.5B (9.3% of revenue), including $312M from the CHIPS Act tax credit.
Cash flow from operations for the trailing 12 months was $6.4B (40.1% of revenue), down 12% year-over-year.
Outlook and guidance
Q3 2024 revenue expected between $3.94B and $4.26B; EPS guidance is $1.24-$1.48.
Effective tax rate expected to remain at 13%.
CapEx for 2024 guided at $5B; depreciation for 2024 expected at $1.5-$1.6B, and $2.0-$2.3B for 2025.
Management will provide more details on capacity investments and financial scenarios in an August capital management call.
Management remains focused on long-term free cash flow per share growth and continued investment in manufacturing and technology.
Latest events from Texas Instruments
- Q4 2025 revenue up 10% YoY to $4.42B; $6.5B returned to shareholders.TXN
Q4 20259 Jul 2026 - Flexible CapEx and 300mm fab expansion target higher free cash flow per share by 2026.TXN
Capital Management Update9 Jul 2026 - 2026 CapEx set at $2–$3B, with disciplined capital allocation and strong market positioning.TXN
Investor Update8 Jul 2026 - Long-term FCF growth driven by disciplined capital allocation, 300mm expansion, and market focus.TXN
Capital Management Update8 Jul 2026 - Q3 revenue up 14% year-over-year to $4.74B; net income $1.36B; $6.6B returned to shareholders.TXN
Q3 20258 Jul 2026 - Capital investment, automotive/industrial growth, and China strategy drive long-term outlook.TXN
Goldman Sachs Communacopia + Technology Conference8 Jul 2026 - Internal capacity expansion and flexible inventory strategies position for growth and market share gains.TXN
UBS Global Technology and AI Conference8 Jul 2026 - All company proposals passed; the shareholder proposal for special meeting rights was rejected.TXN
AGM 202530 Jun 2026 - Capacity expansion and internalization set the stage for growth and margin improvement.TXN
Bernstein 42nd Annual Strategic Decisions Conference3 Jun 2026